Aztreonam + l ? arginine

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes asenapine 5/10 mg- under development. It belongs to central nervous system finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes asenapine maleate. It belongs to antipsycotic apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes atomoxetine hcl. It belongs to antideperessant apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes atorvastatin calcium (crystalline & amorphous). It belongs to antihyperlipidemic apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes azathioprine. It belongs to immunosuppresant apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes azithromycin dihydrate. It belongs to lypholised powder ready to fill category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes balofloxacin. It belongs to quinolone apis products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bendamustin hcl. It belongs to antineoplastic apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bendamustine 100 mg*. It belongs toalyophilised injections finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes besifloxacin. It belongs to quinolone apis products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem 300 mg / 600 mg* --- under development. It belobgs to carbapenem finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem*. It belongs to antibacterial ( betalactum ) apis products category. Contact us for more information.

Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.